News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

La Jolla Pharmaceutical Company (LJPC) To Present At 26th Annual ROTH Growth Stock Conference


3/5/2014 9:12:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool 

newsletter today!

La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the “Company” or “La Jolla”), a biotechnology company developing therapeutics targeting significant unmet, life-threatening diseases today announced that George Tidmarsh, MD, PhD, President and CEO of La Jolla will be presenting a corporate update at the 26th Annual ROTH Conference on March 10, 2014 at 2:30 PM pacific time. An update on the phase 2 clinical study of GCS-100 for the treatment of chronic kidney disease will be included in the presentation.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES